Benjamin J Solomon (Ben Solomon, Benjamin Solomon)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 35

Top Topics

Tyrosine Kinase

Metastatic Colorectal Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Yu-Kuan Huang, Kah Min Yap, Nicole Y L Saw, Jasmine Li, Amanda X Y Chen, Cheok Weng Chan, Emily B Derrick, Kirsten L Todd, Junming Tong, Phoebe A Dunbar, Jiawen Li, Thang X Hoang, Maria N de Menezes, Emma V Petley, Joelle S Kim, Dat Nguyen, Patrick S K Leung, Joan So, Christian Deo T Deguit, Joe Jiang Zhu, Imran G House, Lev M Kats, Andrew M Scott, Benjamin J Solomon, Simon James Harrison, Jane Oliaro, Ian A Parish, Kylie M Quinn, Paul Joseph Neeson, Clare Y Slaney, Junyun Lai, Paul A Beavis, Phillip K Darcy
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John, Steven Kao, Genni Newnham, Kenneth O'Byrne, Sagun Parakh, Victoria Bray, Kevin Jasas, Sonia Yip, Stephen Q Wong, Sarah Ftouni, Jerick Guinto, Sushma Chandrashekar, Stephen Clarke, Nick Pavlakis, Martin R Stockler, Sarah-Jane Dawson, Benjamin J Solomon
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE. Nature communications 15 (1) (2024)
Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Yu-Kuan Huang, Kah Min Yap, Nicole Y L Saw, Jasmine Li, Amanda X Y Chen, Cheok Weng Chan, Emily B Derrick, Kirsten L Todd, Junming Tong, Phoebe A Dunbar, Jiawen Li, Thang X Hoang, Maria N de Menezes, Emma V Petley, Joelle S Kim, Dat Nguyen, Patrick S K Leung, Joan So, Christian Deo T Deguit, Joe Jiang Zhu, Imran G House, Lev M Kats, Andrew M Scott, Benjamin J Solomon, Simon James Harrison, Jane Oliaro, Ian A Parish, Kylie M Quinn, Paul Joseph Neeson, Clare Y Slaney, Junyun Lai, Paul A Beavis, Phillip K Darcy
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature (2024)
Kortnye Smith, Sophie O'Haire, Benjamin Markman, Hui Kong Gan, Kenneth J O'Byrne, Michael Millward, Ben Tran, Benjamin J Solomon, Clare L Scott, Damien Kee, Grant A McArthur, Andrew P Fellowes, Dong Anh K Khoung-Quang, Paul G Ekert, Paul A James, Huiling Xu, Melissa Martyn, Elly Lynch, Rona Weerasuriya, Clara L Gaff, Stephen B Fox, Jayesh Desai
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery. JCO precision oncology 8 (2024)
Benjamin J Solomon, Geoffrey Liu, Enriqueta Felip Font, Tony S K Mok, Ross Andrew Soo, Julien Mazieres, Alice T Shaw, Filippo de Marinis, Yasushi Goto, Yi-Long Wu, Dong Wan Kim, Jean-Francois Martini, Rossella Messina, Jolanda Paolini, Anna Polli, Despina Thomaidou, Francesca Toffalorio, Todd M Bauer
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Yu-Kuan Huang, Kah Min Yap, Nicole Y L Saw, Jasmine Li, Amanda X Y Chen, Cheok Weng Chan, Emily B Derrick, Kirsten L Todd, Junming Tong, Phoebe A Dunbar, Jiawen Li, Thang X Hoang, Maria N de Menezes, Emma V Petley, Joelle S Kim, Dat Nguyen, Patrick S K Leung, Joan So, Christian Deo T Deguit, Joe Jiang Zhu, Imran G House, Lev M Kats, Andrew M Scott, Benjamin J Solomon, Simon James Harrison, Jane Oliaro, Ian A Parish, Kylie M Quinn, Paul Joseph Neeson, Clare Y Slaney, Junyun Lai, Paul A Beavis, Phillip K Darcy
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature 629 (8010) (2024)
Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Yu-Kuan Huang, Kah Min Yap, Nicole Y L Saw, Jasmine Li, Amanda X Y Chen, Cheok Weng Chan, Emily B Derrick, Kirsten L Todd, Junming Tong, Phoebe A Dunbar, Jiawen Li, Thang X Hoang, Maria N de Menezes, Emma V Petley, Joelle S Kim, Dat Nguyen, Patrick S K Leung, Joan So, Christian Deo T Deguit, Joe Jiang Zhu, Imran G House, Lev M Kats, Andrew M Scott, Benjamin J Solomon, Simon James Harrison, Jane Oliaro, Ian A Parish, Kylie M Quinn, Paul Joseph Neeson, Clare Y Slaney, Junyun Lai, Paul A Beavis, Phillip K Darcy
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature 629 (8010) (2024)
Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Yu-Kuan Huang, Kah Min Yap, Nicole Y L Saw, Jasmine Li, Amanda X Y Chen, Cheok Weng Chan, Emily B Derrick, Kirsten L Todd, Junming Tong, Phoebe A Dunbar, Jiawen Li, Thang X Hoang, Maria N de Menezes, Emma V Petley, Joelle S Kim, Dat Nguyen, Patrick S K Leung, Joan So, Christian Deo T Deguit, Joe Jiang Zhu, Imran G House, Lev M Kats, Andrew M Scott, Benjamin J Solomon, Simon James Harrison, Jane Oliaro, Ian A Parish, Kylie M Quinn, Paul Joseph Neeson, Clare Y Slaney, Junyun Lai, Paul A Beavis, Phillip K Darcy
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature 629 (8010) (2024)
Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Yu-Kuan Huang, Kah Min Yap, Nicole Y L Saw, Jasmine Li, Amanda X Y Chen, Cheok Weng Chan, Emily B Derrick, Kirsten L Todd, Junming Tong, Phoebe A Dunbar, Jiawen Li, Thang X Hoang, Maria N de Menezes, Emma V Petley, Joelle S Kim, Dat Nguyen, Patrick S K Leung, Joan So, Christian Deo T Deguit, Joe Jiang Zhu, Imran G House, Lev M Kats, Andrew M Scott, Benjamin J Solomon, Simon James Harrison, Jane Oliaro, Ian A Parish, Kylie M Quinn, Paul Joseph Neeson, Clare Y Slaney, Junyun Lai, Paul A Beavis, Phillip K Darcy
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature 629 (8010) (2024)
Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John, Steven Kao, Genni Newnham, Kenneth O'Byrne, Sagun Parakh, Victoria Bray, Kevin Jasas, Sonia Yip, Stephen Q Wong, Sarah Ftouni, Jerick Guinto, Sushma Chandrashekar, Stephen Clarke, Nick Pavlakis, Martin R Stockler, Sarah-Jane Dawson, Benjamin J Solomon
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE. Nature communications 15 (1) (2024)
Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Yu-Kuan Huang, Kah Min Yap, Nicole Y L Saw, Jasmine Li, Amanda X Y Chen, Cheok Weng Chan, Emily B Derrick, Kirsten L Todd, Junming Tong, Phoebe A Dunbar, Jiawen Li, Thang X Hoang, Maria N de Menezes, Emma V Petley, Joelle S Kim, Dat Nguyen, Patrick S K Leung, Joan So, Christian Deo T Deguit, Joe Jiang Zhu, Imran G House, Lev M Kats, Andrew M Scott, Benjamin J Solomon, Simon James Harrison, Jane Oliaro, Ian A Parish, Kylie M Quinn, Paul Joseph Neeson, Clare Y Slaney, Junyun Lai, Paul A Beavis, Phillip K Darcy
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature 629 (8010) (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John, Steven Kao, Genni Newnham, Kenneth O'Byrne, Sagun Parakh, Victoria Bray, Kevin Jasas, Sonia Yip, Stephen Q Wong, Sarah Ftouni, Jerick Guinto, Sushma Chandrashekar, Stephen Clarke, Nick Pavlakis, Martin R Stockler, Sarah-Jane Dawson, Benjamin J Solomon
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE. Nature communications 15 (1) (2024)
Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Yu-Kuan Huang, Kah Min Yap, Nicole Y L Saw, Jasmine Li, Amanda X Y Chen, Cheok Weng Chan, Emily B Derrick, Kirsten L Todd, Junming Tong, Phoebe A Dunbar, Jiawen Li, Thang X Hoang, Maria N de Menezes, Emma V Petley, Joelle S Kim, Dat Nguyen, Patrick S K Leung, Joan So, Christian Deo T Deguit, Joe Jiang Zhu, Imran G House, Lev M Kats, Andrew M Scott, Benjamin J Solomon, Simon James Harrison, Jane Oliaro, Ian A Parish, Kylie M Quinn, Paul Joseph Neeson, Clare Y Slaney, Junyun Lai, Paul A Beavis, Phillip K Darcy
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature 629 (8010) (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Maurice Pérol, Benjamin J Solomon, Koichi Goto, Keunchil Park, Ernest Nadal, Emilio Bria, Claudio Marcelo Martin, Jair Bar, Justin N Williams, Tarun Puri, Jian Li, Minji K Uh, Boris K Lin, Caicun Zhou
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Daniel Shao-Weng Tan, Enriqueta Felip Font, Gilberto de Castro Junior, Benjamin J Solomon, Alastair P Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis G Paz-Ares, Jaafar Bennouna, Marina-Chiara Garassino, Michael Schenker, Sang-We Kim, Jan C Brase, Denise Bury-Maynard, Vanessa Q Passos, Stéphanie Deudon, Bharani Dharan, Yuanbo Song, Rafael Caparica, Bruce E Johnson
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
Phase Ib/II Trial of BRAF and EGFR inhibition in BRAFV600E metastatic colorectal cancer and other cancers: EVICT (Erlotinib and Vemurafenib In Combination Trial). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Deborah Meyran, Joe Jiang Zhu, Jeanne Butler, Daniela Tantalo, Sean MacDonald, Thu Ngoc Nguyen, Minyu Wang, Niko Thio, Criselle D'Souza, Vicky Mengfei Qin, Clare Y Slaney, Aaron Harrison, Kevin Sek, Pasquale Petrone, Kevin Thia, Lauren Giuffrida, Andrew Mark Scott, Rachael L Terry, Ben Tran, Jayesh Desai, Henry Miles Prince, Simon James Harrison, Paul A Beavis, Michael H Kershaw, Benjamin J Solomon, Paul G Ekert, Joseph A Trapani, Phillip K Darcy, Paul Joseph Neeson
T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models. Science translational medicine 15 (690) (2023)
Antony J Mersiades, Benjamin J Solomon, Chee Khoon Lee, Michelle M Cummins, Lucille Sebastian, Mandy L Ballinger, Emily Collignon, Olivia Mh Turnbull, Sonia Yip, Rachael Lisa Morton, Chris Brown, Patrick J Wheeler, Malinda Itchins, R John Simes, Nick Pavlakis
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue. Future oncology (London, England) (2023)
Lavinia Tan, Ben Tran, Jeanne Tie, Benjamin Markman, Sumi Ananda, Niall C Tebbutt, Michael Michael, Emma Link, Stephen Q Wong, Sushma Chandrashekar, Jerick Guinto, David S Ritchie, Rachel M Koldej, Benjamin J Solomon, Grant A McArthur, Rodney John Hicks, Peter Gibbs, Sarah-Jane Dawson, Jayesh Desai
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Samuel Rosner, Augusto Valdivia, Hui Jing Hoe, Joseph C Murray, Benjamin Levy, Enriqueta Felip, Benjamin J Solomon
Antibody-Drug Conjugates for Lung Cancer: Payloads and Progress. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43 (2023)
Hui Jing Hoe, Benjamin J Solomon
Optimizing Dosing of Trastuzumab Deruxtecan in HER2 -Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always Better. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luke S McLean, Wasek Faisal, Sagun Parakh, Steven C Kao, Craig R Lewis, Melvin T Chin, Mark Voskoboynik, Malinda J Itchins, Ross R Jennens, Adam R Broad, Tessa A Morris, Benjamin J Solomon
Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease. JCO precision oncology 5 (2022)
Angela Mweempwa, Huiling Xu, Joseph H A Vissers, Richard W Tothill, Andrew D Pattison, Andrew P Fellowes, David M Thomas, Gary Richardson, Rodney John Hicks, Sean M Grimmond, Stephen B Fox, Stephen J Luen, Jayesh Desai, Benjamin J Solomon
Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma. JCO precision oncology 5 (2022)
Alexander E Drilon, Vivek Subbiah, Oliver Gautschi, Pascale Tomasini, Filippo de Braud, Benjamin J Solomon, Daniel Shao-Weng Tan, Guzmán Alonso, Juergen Wolf, Keunchil Park, Koichi Goto, Victoria Soldatenkova, Sylwia Szymczak, Scott S Barker, Tarun Puri, Aimee Bence Lin, Herbert Ho-Fung Loong, Benjamin Besse
Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Benjamin J Solomon, Todd M Bauer, Sai-Hong Ignatius Ou, Geoffrey Liu, Hidetoshi Hayashi, Alessandra Bearz, Konstantin Penkov, Yi-Long Wu, Arrieta Oscar, Jacek Jassem, Anna M Calella, Gerson Peltz, Anna Polli, Holger Thurm, Tony S K Mok
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK -Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (31) (2022)
Brion W Murray, Evan Rogers, Dayong Zhai, Wei Deng, Xi Chen, Paul A Sprengeler, Xin Zhang, Armin Graber, Siegfried H Reich, Shanna Stopatschinskaja, Benjamin J Solomon, Benjamin Besse, Alexander E Drilon
Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations. Molecular cancer therapeutics 20 (12) (2021)
Sherly Mardiana, Benjamin J Solomon, Phillip K Darcy, Paul A Beavis
Supercharging adoptive T cell therapy to overcome solid tumor-induced immunosuppression. Science translational medicine 11 (495) (2020)
Benjamin J Solomon, Cai Cun Zhou, Alexander Drilon, Keunchil Park, Jürgen Wolf, Yasir Elamin, Hannah M Davis, Victoria Soldatenkova, Andreas Sashegyi, Aimee Bence Lin, Boris K Lin, Herbert H F Loong, Silvia Novello, Edurne Arriola, Maurice Pérol, Koichi Goto, Fernando C Santini
Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer. Future oncology (London, England) 17 (7) (2020)